Troncoso P - Search Results

1

Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptors.

Chen EJ, Sowalsky AG, Gao S, Cai C, Voznesensky O, Schaefer R, Loda M, True LD, Ye H, Troncoso P, Lis RL, Kantoff PW, Montgomery RB, Nelson PS, Bubley GJ, Balk SP, Taplin ME. Chen EJ, et al. Among authors: troncoso p. Clin Cancer Res. 2015 Mar 15;21(6):1273-80. doi: 10.1158/1078-0432.CCR-14-1220. Epub 2014 Oct 15. Clin Cancer Res. 2015. PMID: 25320358 Free PMC article.

2

Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer.

McDonnell TJ, Troncoso P, Brisbay SM, Logothetis C, Chung LW, Hsieh JT, Tu SM, Campbell ML. McDonnell TJ, et al. Among authors: troncoso p. Cancer Res. 1992 Dec 15;52(24):6940-4. Cancer Res. 1992. PMID: 1458483

3

Consistent expression of an epithelial cell adhesion molecule (C-CAM) during human prostate development and loss of expression in prostate cancer: implication as a tumor suppressor.

Kleinerman DI, Troncoso P, Lin SH, Pisters LL, Sherwood ER, Brooks T, von Eschenbach AC, Hsieh JT. Kleinerman DI, et al. Among authors: troncoso p. Cancer Res. 1995 Mar 15;55(6):1215-20. Cancer Res. 1995. PMID: 7533659

4

Establishment of two human prostate cancer cell lines derived from a single bone metastasis.

Navone NM, Olive M, Ozen M, Davis R, Troncoso P, Tu SM, Johnston D, Pollack A, Pathak S, von Eschenbach AC, Logothetis CJ. Navone NM, et al. Among authors: troncoso p. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2493-500. Clin Cancer Res. 1997. PMID: 9815652

5

Trisomy 7 by dual-color fluorescence in situ hybridization: a potential biological marker for prostate cancer progression.

Wang RY, Troncoso P, Palmer JL, El-Naggar AK, Liang JC. Wang RY, et al. Among authors: troncoso p. Clin Cancer Res. 1996 Sep;2(9):1553-8. Clin Cancer Res. 1996. PMID: 9816332

6

TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.

Navone NM, Rodriquez-Vargas MC, Benedict WF, Troncoso P, McDonnell TJ, Zhou JH, Luthra R, Logothetis CJ. Navone NM, et al. Among authors: troncoso p. Clin Cancer Res. 2000 Mar;6(3):1190-7. Clin Cancer Res. 2000. PMID: 10741751

7

Relative expression of type IV collagenase, E-cadherin, and vascular endothelial growth factor/vascular permeability factor in prostatectomy specimens distinguishes organ-confined from pathologically advanced prostate cancers.

Kuniyasu H, Troncoso P, Johnston D, Bucana CD, Tahara E, Fidler IJ, Pettaway CA. Kuniyasu H, et al. Among authors: troncoso p. Clin Cancer Res. 2000 Jun;6(6):2295-308. Clin Cancer Res. 2000. PMID: 10873080

8

Activator protein 2alpha transcription factor expression is associated with luminal differentiation and is lost in prostate cancer.

Ruiz M, Troncoso P, Bruns C, Bar-Eli M. Ruiz M, et al. Among authors: troncoso p. Clin Cancer Res. 2001 Dec;7(12):4086-95. Clin Cancer Res. 2001. PMID: 11751506

9

The association of p21((WAF-1/CIP1)) with progression to androgen-independent prostate cancer.

Fizazi K, Martinez LA, Sikes CR, Johnston DA, Stephens LC, McDonnell TJ, Logothetis CJ, Trapman J, Pisters LL, Ordoñez NG, Troncoso P, Navone NM. Fizazi K, et al. Among authors: troncoso p. Clin Cancer Res. 2002 Mar;8(3):775-81. Clin Cancer Res. 2002. PMID: 11895908

10

Ki-67 staining is an independent correlate of biochemical failure in prostate cancer treated with radiotherapy.

Cowen D, Troncoso P, Khoo VS, Zagars GK, von Eschenbach AC, Meistrich ML, Pollack A. Cowen D, et al. Among authors: troncoso p. Clin Cancer Res. 2002 May;8(5):1148-54. Clin Cancer Res. 2002. PMID: 12006531

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

331 results

Search Page

Filters